Dr. Abal currently heads the Laboratory of Translational Medical Oncology of the Hospital of the University of Santiago de Compostela (SERGAS), and is the senior researcher (I3SNS Programme) of the Health Research Institute of Santiago – IDIS. Dr. Abal has patents related to oncological diagnosis and to the treatment of metastatic disease.
He is the author of over 50 publications primarily in gynaecological and colorectal cancers. He is a founding partner of the spin-offs Transbiomed and NasasBiotech, both biotechnology companies dedicated to products and technology for diagnosis and therapy in oncology. Dr. Abal has a degree in pharmacy from the University of Santiago de Compostela and Doctor of Pharmacy from the Biological Research Center CIB – CSIC in Madrid.